Prognostic Value of Dynamic Contrast-Enhanced MRI-Derived Pharmacokinetic Variables in Glioblastoma Patients: Analysis of Contrast-Enhancing Lesions and Non-Enhancing T2 High-Signal Intensity Lesions

OBJECTIVE: To evaluate pharmacokinetic variables from contrast-enhancing lesions (CELs) and non-enhancing T2 high signal intensity lesions (NE-T2HSILs) on dynamic contrast-enhanced (DCE) magnetic resonance (MR) imaging for predicting progression-free survival (PFS) in glioblastoma (GBM) patients. MA...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Korean J Radiol
Autores principales: Kang, Yeonah, Hong, Eun Kyoung, Rhim, Jung Hyo, Yoo, Roh-Eul, Kang, Koung Mi, Yun, Tae Jin, Kim, Ji-Hoon, Sohn, Chul-Ho, Park, Sun-Won, Choi, Seung Hong
Formato: Artigo
Lenguaje:Inglês
Publicado: The Korean Society of Radiology 2020
Materias:
Neuroimaging and Head & Neck
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7231611/
https://ncbi.nlm.nih.gov/pubmed/32410409
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3348/kjr.2019.0629
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares